Compound Detail
CHEMBL4650241
DELANDISTROGENE MOXEPARVOVEC 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL4650241 |
| Name | DELANDISTROGENE MOXEPARVOVEC |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
3
Known Names
2
Indications
1
Mechanisms
Drug Information
| Molecule Type | Gene |
| First Approval | 2023 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Dystrophin exogenous gene | EXOGENOUS GENE | Dystrophin | ✓ | ✓ |
Indications
Muscular Dystrophy, Duchenne Muscular Dystrophy, Duchenne
ATC Classification
M09AX15
delandistrogene moxeparvovec
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
Data from ChEMBL 36 via Core Engine